Related Experiment Video
Updated: Mar 31, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Caspase-3 feedback loop enhances Bid-induced AIF/endoG and Bak activation in Bax and p53-independent manner
1Department of Abdominal Oncology, State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, 17# People's South Road, Chengdu, Chengdu 610041, PR China.
Abstract:
Chemoresistance in cancer has previously been attributed to gene mutations or deficiencies. Bax or p53 deficiency can lead to resistance to cancer drugs. We aimed to find an agent to overcome chemoresistance induced by Bax or p53 deficiency. Here, we used immunoblot, flow-cytometry analysis, gene interference, etc. to show that genistein, a major component of isoflavone that is known to have anti-tumor activities in a variety of models, induces Bax/p53-independent cell death in HCT116 Bax knockout (KO), HCT116 p53 KO, DU145 Bax KO, or DU145 p53 KO cells that express wild-type (WT) Bak. Bak knockdown (KD) only partially attenuated genistein-induced apoptosis. Further results indicated that the release of AIF and endoG also contributes to genistein-induced cell death, which is independent of Bak activation. Conversely, AIF and endoG knockdown had little effect on Bak activation. Knockdown of either AIF or endoG alone could not efficiently inhibit apoptosis in cells treated with genistein, whereas an AIF, endoG, and Bak triple knockdown almost completely attenuated apoptosis. Next, we found that the Akt-Bid pathway mediates Bak-induced caspase-dependent and AIF- and endoG-induced caspase-independent cell death. Moreover, downstream caspase-3 could enhance the release of AIF and endoG as well as Bak activation via a positive feedback loop. Taken together, our data elaborate the detailed mechanisms of genistein in Bax/p53-independent apoptosis and indicate that caspase-3-enhanced Bid activation initiates the cell death pathway. Our results also suggest that genistein may be an effective agent for overcoming chemoresistance in cancers with dysfunctional Bax and p53.
Insights
Genistein induces cancer cell death independently of Bax or p53, offering a potential treatment for chemoresistance. This compound activates cell death pathways involving Bak, AIF, and endoG, even when Bax or p53 are deficient.
Area of Science:
- * Molecular Biology
- * Cancer Research
- * Cell Death Mechanisms
Background:
- * Chemoresistance in cancer is often linked to gene mutations or deficiencies, such as in Bax or p53.
- * Existing cancer therapies face challenges when tumors develop resistance due to these genetic alterations.
Purpose of the Study:
- * To identify an agent capable of overcoming chemoresistance caused by Bax or p53 deficiency.
- * To elucidate the molecular mechanisms underlying genistein-induced cell death in cancer cells with deficient Bax or p53.
Main Methods:
- * Utilized immunoblotting and flow-cytometry analysis to assess cell death.
- * Employed gene interference techniques, including knockdown (KD) and knockout (KO) models (HCT116, DU145 cells).
- * Investigated the roles of Bak, Apoptosis-Inducing Factor (AIF), and endonuclease G (endoG) in genistein-induced apoptosis.
Main Results:
- * Genistein induced Bax/p53-independent apoptosis in cancer cells lacking Bax or p53 but expressing wild-type Bak.
- * Bak knockdown only partially reduced genistein-induced apoptosis, indicating involvement of other pathways.
- * Release of AIF and endoG contributed to cell death independently of Bak activation.
- * A combination of AIF, endoG, and Bak knockdown almost completely abolished genistein-induced apoptosis.
- * The Akt-Bid pathway mediated both Bak-dependent (caspase-dependent) and AIF/endoG-dependent (caspase-independent) cell death.
- * Caspase-3 activation created a positive feedback loop, enhancing AIF/endoG release and Bak activation.
Conclusions:
- * Genistein effectively induces cancer cell death through Bax/p53-independent mechanisms.
- * Caspase-3 activation, via the Akt-Bid pathway, initiates genistein-induced apoptosis through a positive feedback loop.
- * Genistein shows promise as a therapeutic agent for overcoming chemoresistance in cancers with dysfunctional Bax and p53 pathways.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Amplifying Signals via Enzymatic Cascade
MAPK Signaling Cascades
The JAK-STAT Signaling Pathway

